Skip to main content
Clinical Trials/CTRI/2022/07/043968
CTRI/2022/07/043968
Recruiting
未知

A Prospective, Multicenter, Observational Registry of Metastatic Colorectal cancer (mCRC) Disease to determine Demographics, Clinical features, Molecularfeatures and Treatment outcomes in patients undergoing treatment at participating centers.

Dr Reddys Laboratories0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C189- Malignant neoplasm of colon, unspecified
Sponsor
Dr Reddys Laboratories
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Dr Reddys Laboratories

Eligibility Criteria

Inclusion Criteria

  • ? Metastatic adenocarcinoma of colon or rectum
  • ? Inoperable and eligible for first line systemic therapy
  • ? Age \= 18yrs.
  • ? Signed informed consent.

Exclusion Criteria

  • ? Any participants who received his or her treatment at
  • participating study sites prior to enrolment except for
  • patients with metachronous mCRC
  • ? Non\-metastatic Colorectal cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials